Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database.
Emmett L, Papa N, Counter W, Calais J, Barbato F, Burger I, Eiber M, Roberts MJ, Agrawal S, Franklin A, Xue A, Rasiah K, John N, Moon D, Frydenberg M, Yaxley J, Stricker P, Wong K, Coughlin G, Gianduzzo T, Kua B, Ho B, Nguyen A, Liu V, Lee J, Hsiao E, Sutherland T, Perry E, Fendler WP, Hope TA. Emmett L, et al. Among authors: barbato f. J Nucl Med. 2024 Jan 2;65(1):94-99. doi: 10.2967/jnumed.123.266164. J Nucl Med. 2024. PMID: 38050155
Therapeutic Strategies in HCC: Radiation Modalities.
Gallicchio R, Nardelli A, Mainenti P, Nappi A, Capacchione D, Simeon V, Sirignano C, Abbruzzi F, Barbato F, Landriscina M, Storto G. Gallicchio R, et al. Among authors: barbato f. Biomed Res Int. 2016;2016:1295329. doi: 10.1155/2016/1295329. Epub 2016 Aug 3. Biomed Res Int. 2016. PMID: 27563661 Free PMC article. Review.
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
Nappi A, Gallicchio R, Simeon V, Nardelli A, Pelagalli A, Zupa A, Vita G, Venetucci A, Di Cosola M, Barbato F, Storto G. Nappi A, et al. Among authors: barbato f. Radiol Oncol. 2015 Nov 27;49(4):320-6. doi: 10.1515/raon-2015-0043. eCollection 2015 Dec. Radiol Oncol. 2015. PMID: 26834517 Free PMC article.
68Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study.
Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K, Fendler WP. Farolfi A, et al. Among authors: barbato f. J Urol. 2019 Dec;202(6):1174-1181. doi: 10.1097/JU.0000000000000417. Epub 2019 Jun 24. J Urol. 2019. PMID: 31233369
Reply by Authors.
Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K, Fendler WP. Farolfi A, et al. Among authors: barbato f. J Urol. 2019 Dec;202(6):1181. doi: 10.1097/01.JU.0000582680.86998.12. Epub 2019 Sep 16. J Urol. 2019. PMID: 31524577 No abstract available.
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET.
Farolfi A, Ilhan H, Gafita A, Calais J, Barbato F, Weber M, Afshar-Oromieh A, Spohn F, Wetter A, Rischpler C, Hadaschik B, Pianori D, Fanti S, Haberkorn U, Eiber M, Herrmann K, Fendler WP. Farolfi A, et al. Among authors: barbato f. J Nucl Med. 2020 Jul;61(7):1037-1042. doi: 10.2967/jnumed.119.235374. Epub 2019 Dec 5. J Nucl Med. 2020. PMID: 31806773 Free PMC article.
First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using 68Ga-PSMA-11.
Darr C, Krafft U, Fendler WP, Costa PF, Barbato F, Praus C, Reis H, Hager T, Tschirdewahn S, Radtke JP, Herrmann K, Hadaschik BA. Darr C, et al. Among authors: barbato f. Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):3194-3195. doi: 10.1007/s00259-020-04778-y. Epub 2020 Apr 30. Eur J Nucl Med Mol Imaging. 2020. PMID: 32356006 No abstract available.
Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma.
Ferdinandus J, Barbato F, Chodyla M, Fendler WP, Kessler L, Pomykala KL, Metzenmacher M, Krefting F, Hager T, Umutlu L, Herrmann K, Christoph DC. Ferdinandus J, et al. Among authors: barbato f. J Nucl Med. 2021 Feb;62(2):191-194. doi: 10.2967/jnumed.120.245803. Epub 2020 Jun 12. J Nucl Med. 2021. PMID: 32532926 Free article.
161 results